Not finding it? Sign in to also search OpenAlex live.
-
Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early‐Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized‐Controlled Trials2026 Clinical and Translational Science article Health Professions Clinical Laboratory Practices and Quality Control Open access
Jannik Rousel, Tessa Niemeyer‐van der Kolk, Matthijs Moerland, Robert Rißmann, Naomi B. Klarenbeek, Maurits F. J. M. Vissers, +1 more
0citations -
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
Philippe Gabríel Steg, Michael J. Szarek, J. Wouter Jukema, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, +81 more
31citations -
Modulating Placebo Effects in Clinical Trials: Study Team Briefing to Optimize Drug–Placebo Differences2025 Clinical and Translational Science article Neuroscience Pain Management and Placebo Effect Open access
Martin Coenen, Ulrike Bingel, Maria Soledad Berdaguer, Christine Fuhrmann, Robert Németh, Jens Rengelshausen, +3 more
0citations -
De BUSCOPAN-studie. Een gerandomiseerde non-inferioriteitsstudie van continue butylscopolamine-infusie versus placebo voor niersteenkoliek onvoldoende reagerend op non-steroïdale anti-inflammatoire medicatie2022 Tijdschrift voor Urologie article Medicine Kidney Stones and Urolithiasis Treatments Open access
Saskia Weltings, K. Tim Buddingh, Daniëlle C. van Diepen, Rob C.M. Pelger, Hein Putter, Mandana Rad, +2 more
0citations -
#3848 ORIGIN TRIAL: 24-WK PRIMARY ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PH2B STUDY OF ATACICEPT IN PATIENTS WITH IGAN2023 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Richard A. Lafayette, Bart Maes, Celia J. F. Lin, Sean J. Barbour, Richard K. S. Phoon, Sung Gyun Kim, +4 more
14citations -
Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation.2025 Journal of Clinical Oncology article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Alexander C. J. van Akkooi, Mario Mandalà, Michal Kiciński, Anne-Sophie Govaerts, Axel Hauschild, Piotr Lukasz Rutkowski, +14 more
0citations -
Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups
Sonia Jaramillo Segura, Maxi Wass, Judith Schaffrath, Kathrin Rieger, Axel Nogai, Mathias Haenel, +46 more
5citations -
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT)
Andreas Bechdolf, Hendrik Müller, Martin Hellmich, Walter de Millas, Peter Falkai, Wolfgang Gäebel, +18 more
22citations -
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial
Stewart J. Tepper, Henrik Winther Schytz, R O B V Jensen, Christofer Lundqvist, Gisela Marie Terwindt, Cristina Tassorelli, +8 more
1citations -
Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma
Emanuel Bührer, Nina Glassée, Michal Kiciński, Oliver John Kennedy, Christian U. Blank, Georgina Venetia Long, +26 more
0citations -
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent
Jürgen Floege, Richard A. Lafayette, Jonathan Barratt, Brian S. Schwartz, Paul T. Manser, Uptal D. Patel, +7 more
47citations -
primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma2026 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Alexander C. J. van Akkooi, Michal Kiciński, Anne-Sophie Govaerts, Axel Hauschild, Piotr Lukasz Rutkowski, Petr Arenberger, +32 more
1citations -
MON-297 Withdrawal from Long-Acting Somatostatin Receptor Ligand Injections in Adult Patients with Acromegaly: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study2020 Journal of the Endocrine Society article Medicine Pituitary Gland Disorders and Treatments Open access
Lisa B. Nachtigall, Susan Leanne Samson, Maria Fleseriu, Marek Bolanowski, William Henry Ludlam, Gary Patou, +7 more
0citations -
Guselkumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients: results of the phase III randomized placebo-controlled PROTOSTAR study2024 British Journal of Dermatology article Immunology and Microbiology Psoriasis: Treatment and Pathogenesis Open access
Vimal H. Prajapati, Marieke M.B. Seyger, Dagmar Wilsmann‐Theis, Erzsébet Szakos, Andrzej Kaszuba, Bart van Hartingsveldt, +6 more
12citations -
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial2024 European Journal of Endocrinology article Medicine Pharmacology and Obesity Treatment Open access
Blandine Gatta‐Cherifi, Kamel Mohammedi, Tanguy Cariou, Christine Poitou, Philippe A. Touraine, Gérald Raverot, +11 more
27citations -
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial2021 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Bernard G Combe, Alan Kivitz, Yoshiya Tanaka, Désirée M F M van der Heijde, Jesus Abraham Simón Campos, Herbert S. B. Baraf, +14 more
248citations -
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)
Zahra Nochi, H. W. Pia, Petra Bloms‐Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, +25 more
6citations -
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity
Caterina Maria Leone, Giulia Di Stefano, Giuseppe Di Pietro, Petra Bloms‐Funke, Irmgard Boesl, Ombretta Caspani, +22 more
10citations -
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)
André Mouraux, Petra Bloms‐Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Giulia Di Stefano, +18 more
6citations -
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
Nini de Boer, Sinan Gülöksüz, Caroline G. C. M. van Baal, Leonie Willebrands, Jeroen Deenik, Christiaan H. Vinkers, +18 more
5citations